ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SGHT Sight Sciences Inc

5.13
-0.11 (-2.10%)
After Hours
Last Updated: 16:16:49
Delayed by 15 minutes

Period:

Draw Mode:

Volume 134,675
Bid Price 4.50
Ask Price 6.00
News -
Day High 5.445

Low
1.04

52 Week Range

High
11.20

Day Low 5.00
Company Name Stock Ticker Symbol Market Type
Sight Sciences Inc SGHT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.11 -2.10% 5.13 16:16:49
Open Price Low Price High Price Close Price Prev Close
5.19 5.00 5.445 5.13 5.24
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,913 134,675 $ 5.19 $ 698,497 - 1.04 - 11.20
Last Trade Time Type Quantity Stock Price Currency
16:03:12 priorref 100 $ 5.13 USD

Sight Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
253.22M 49.55M - 81.06M -55.55M -1.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sight Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SGHT Message Board. Create One! See More Posts on SGHT Message Board See More Message Board Posts

Historical SGHT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.106.195.005.41119,474-0.97-15.90%
1 Month5.156.34254.885.49197,445-0.02-0.39%
3 Months4.726.34254.014.81173,6770.418.69%
6 Months3.776.34251.043.87442,5941.3636.07%
1 Year8.7911.201.044.48308,514-3.66-41.64%
3 Years30.0042.571.0411.43269,563-24.87-82.90%
5 Years30.0042.571.0411.43269,563-24.87-82.90%

Sight Sciences Description

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Your Recent History

Delayed Upgrade Clock